Weiss Multi Strategy Advisers LLC Ionis Pharmaceuticals Inc Transaction History

Weiss Multi Strategy Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $170,148 - $205,710	-5,073 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $175,221 - $239,699	5,073 New	5,073 $202,000
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $538,500 - $652,700	-10,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $310,450 - $430,700	-5,000 Reduced 33.33%	10,000 $643,000
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $264,600 - $405,850	-5,000 Reduced 25.0%	15,000 $1.22 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $221,880 - $304,606	-5,116 Reduced 20.37%	20,000 $1.08 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $4,974 - $6,229	116 Added 0.46%	25,116 $1.3 Million
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $220,400 - $275,250	5,000 Added 25.0%	25,000 $1.1 Million
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $1.01 Million - $1.29 Million	20,000	20,000 $1.01 Million

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.